Zhejiang Kangci Medical Technology Co., Ltd. engages in the production and sale of medical devices. Its business activities include technology development, technical services, and technical consulting related to medical devices and equipment, medical device applications, biotechnology, and medicine and health products. Its products include medical teaching models, metal materials, electronic products, fitness equipment, and mechanical and electrical products. It also provides non-medical health consultation services. The company was founded on March 15, 2012 and is headquartered in Quzhou, China.

Yungjin Pharm. Co., Ltd. engages in the development, production, and distribution of pharmaceuticals. Its products include cephalosporin, antibiotics, drugs for the central nervous system, cardiovascular, endocrine system, urinary system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, vitamin and supplement, cosmetics, and tonic drinks. The company was founded on July 16, 19672 and is headquartered in Seoul, South Korea.

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. It operates through the following segments: Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others. The Medical Device Products segment produces and sells clinical care, wound management, medical testing, anesthesia, surgical related products, and other consumables. The Orthopaedic Products segment focuses on the provision of orthopaedic products. The Interventional Products segment consists of tumour and blood vessel interventional instruments. The Pharma Packaging Products includes pre-filled syringes and flushing syringes. The Blood Management Products segment refers to blood collection, irradiation, storage, separation, and sterilization products. The Others segment pertains to the finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.

Zaporizhzhia State Medical University (ZSMU) is a medical university in the small city of Zaporizhzhia, Ukraine.

The First Hospital of Jilin University, a subsidiary of Jilin University, is a Chinese company located in Changchun. The firm owns and operates hospital.

Beijing Jishuitan Hospital (JST Hospital; simplified Chinese: 北京积水潭医院; traditional Chinese: 北京積水潭醫院), is a large-scaled first-level hospital in Beijing, focusing mainly on orthopaedics and burn surgery. Founded in 1956, the hospital now has around 1000 beds. Its performance in medical care, teaching and researching led to it becoming the Fourth Medical College of Peking University. The hospital now has 200 doctors and 2200 other staff. The hospital has fully equipped departments of orthopaedics, spine surgery, adult joint reconstructive surgery, orthopaedic trauma, hand surgery, paediatric orthopaedics, bone tumor, sports medicines and burn surgery.

Nanjing Yinhaiyue Biotechnology Co., Ltd., established on 2012-10-11, Business scope includes research and development of cosmetics and hygiene products,Sales;Biotechnology R&D,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

NeTech, Inc., part of Fujikura Kasei Co., Ltd., is a Japanese company located in Kanagawa that develops anti-cancer drugs, medical adhesives and wound dressing and cell diagnosis.

Shanghai Hongyu Medical Technology Co., Ltd., established on 2019-07-05, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Engaged in technical services in the field of medical technology,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Production of Class I Medical Devices,Sales of Class I Medical Devices,Engaged in technology development in the field of biotechnology,technical consulting,technology transfer,Technical Services,Manufacturing of special equipment(Manufacture of equipment without licensed professions),IoT device manufacturing,electronics sales,Pet Food and Supplies Wholesale,Manufacturing of daily necessities,Daily miscellaneous goods sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Dean Medical Technology Co., Ltd., established on 2004-02-26, The scope of business includes engaging in technology development in the medical field,technical consulting,Technical Services,technology transfer;Design of Medical Devices,Production,Sales,Maintenance and technical consultation(Operating with a license involving a licensed project);Self-operated and agent import and export business of various commodities and technologies,Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hangzhou Waseda Biotechnology Co., Ltd., established on 2017-12-13, Business scope includes agricultural and biotechnology research and development,tree planting,Bio-feed R&D,processing,Production;Aquaculture and Processing,Aquatic livestock and poultry application technology research and development,Bio-fermentation technology research and development,food,Edible fungus,production of cosmetics,Sales,And the import and export business of the above products;technology development,Technical Services,Technology transfer(Except those involving the implementation of special access management measures stipulated by the state)**(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)